Ethnic Lip Augmentation With Hyaluronic Acid Filler
Study Details
Study Description
Brief Summary
Lip augmentation using hyaluronic acid filler in females with Fitzpatrick skin type V-VI
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 3 |
Detailed Description
Using the revised Allergan Lip Fullness Scale (LFS) to improve post injection patient satisfaction in women with Fitzpatrick skin type (FPST) 5 and 6 (examples: Hispanic, African descendants, Indigenous Australians).
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Volbella or Juvederm Ultra XC filler Injection will not exceed a total of 4 cc of hyaluronic acid filler for combined treatment sessions (initial treatment + possible touch up treatment session). |
Drug: Volbella or Juvederm Ultra XC filler
Hyaluronic acid filler
|
Outcome Measures
Primary Outcome Measures
- Lip size [1 month]
The size of lip most desired based on the LFS scale. The possible choices are: 1) Minimal: flat or nearly flat contour, minimal red lip show. 2) Mild: some red lip show, no lower lip pout. 3) Moderate: Moderate red lip show with slight lower lip pout. 4) Marked: significant red lip show and lower lip pout, upper lip with moderate pout. 5) Very Marked: very significant red lip show, significant upper and lower lip pout.
- Satisfaction level [1 month]
Satisfaction levels relative to baseline via the FACE-Q questionnaire. The questionnaire asks the following questions: 1) The shape of your lower lip? 2) How well your lips suit your face? 3) How nice your lips look when you smile. 4) How full your lower lip looks? 5) The style of your lips (e.g. pouty, natural)? 6) The shape of your upper lip? 7) How turned up your upper lip (cupids bow) looks? 8) The size of your lips? 9) How the outer corners of your lips look when your face is relaxed (still)? 10) How full your lips look? The possible choices for each question are as follows: very dissatisfied (1), somewhat dissatisfied (2), somewhat satisfied (3), very satisfied (4). Responses of very satisfied signify a more positive outcome. Overall scores closer to 40 signify a more favorable satisfaction level.
Secondary Outcome Measures
- LFS by age group [1 month]
LFS preference by age group (21-40 years old vs. 41+ years old). The size of lip most desired based on the LFS scale. The possible choices are: 1) Minimal: flat or nearly flat contour, minimal red lip show. 2) Mild: some red lip show, no lower lip pout. 3) Moderate: Moderate red lip show with slight lower lip pout. 4) Marked: significant red lip show and lower lip pout, upper lip with moderate pout. 5) Very Marked: very significant red lip show, significant upper and lower lip pout.
- Improvement level [1 month]
Subjects will determine which LFS scale category they would like to be and then based upon final visit they will rate themselves again as to where they actually fall on the scale. Investigator will do the same but only at final visit.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Females age 21 and above, with FPST 5 or 6, undergoing lip filler augmentation
-
Subjects will be required not to have had previous lip filler, fat injections, or other lip treatments in the last 12 months.
-
Subjects that understand the purpose and aspects of the study, freely sign the informed consent, complete the required treatment and follow up protocol.
Exclusion Criteria:
-
Females below the age of 21
-
Male patients
-
Subjects with LFS 5
-
Fitzpatrick skin Type 1-4
-
Subjects who have had previous lip filler, fat injections or other surgical lip augmentation in the last 12 months
-
Subjects who are pregnant or nursing
-
Subjects with a known allergy or sensitivity to any component of the study ingredients.
-
Subjects that do not understand the purpose and aspects of the study, do not sign the consent, and do not complete the required treatment and follow up visit will also be excluded.
-
Subjects with a history of bleeding disorders (Vitamin K deficiency, liver disease, renal disease, iatrogenic or otherwise). This includes persons who have undergone therapy with thrombolytics, anticoagulants, or inhibitors of platelet aggregation in the preceding 3 weeks (such as Coumadin, Plavix, heparin analogues)
-
Subjects should not be taking aspirin, nonsteroidal anti-inflammatory medications, St. John's Wort, or high doses of Vitamin E supplements within 7 days prior to the start of the study
-
Subjects with active inflammation or infection in the area of treatment
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | DeNova Research | Chicago | Illinois | United States | 60611 |
Sponsors and Collaborators
- DeNova Research
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- LIPS-DAYAN-22